A Pilot Study of Metabolic Effects of Intravenously Given Alpha-Calcidol In Patients With Chronicc Renal Failure

References

• Amend WJC, Steinberg SM, Lowrie EG, Lazarus JM, Soeldner JS, Hamper CL, Merrill JP. The influence of serum calcium and parathyroid hormone upon glucose metabolism in uremia. J Lab Clin Med 1985; 86: 435–444.
   Google Scholar
• Chertow BS, Sivitz WI, Baranetsky NG, Clark SA, Waite A, DeLuca HE Cellular mechanisms of insulin release: The effects of vitamin D deficiency and repletion on rat insulin secretion. Endocrinology 1983; 113: 1511–1518.
   Google Scholar
• Christakos S, Norman AW. Studies on the mode of action of calciferol XXIX. Biochemical characterization of 1,25-dihydroxycholecalciferol receptors in chick pancreas and kidney cytosol. Endocrinology 1981; 108: 140–149.
   Google Scholar
• DeFronzo RA, Alvestrand A. Glucose intolerance in uremia: site and mechanism. Am J Clin Nutr 1980; 33: 1438–1445.
   Google Scholar
• Graf H, Prager R, Kovarik J, Luger A, Schernthaner G, Pinggera WF. Glucose metabolism and insulin sensitivity in patients on chronic hemodialysis. Metabolism 1985; 34: 974–977.
   Google Scholar
• Grobbee DE, Hoffman A. Effect of calcium supplementation on diastolic blood pressure in young people with mild hypertension. Lancet 1986; ii: 703–707.
   Google Scholar
• Hehrmann R, Nordmayer JP, Mohr G, Hesch R-D. Human parathyroid hormone: antibody characterization. J Immunoassay 1980; 1: 151–174.
   Google Scholar
• Hvarfner A, Ljunghall S, Morlin C, Wide L, Berg-ström R. Indices of mineral metabolism in relation to blood pressure in a sample of a healthy population. Acta Med Scand 1986; 219: 461–468.
   Google Scholar
• Hvarfner A, Bergstrom R, Mörlin C, Wide L, Ljunghall S. Relationships between calcium metabolic indices and blood pressure in patients with essential hypertension as compared with a healthy population. J Hypertension 1987; 5: 451–456.
   Google Scholar
• Ikkos D, Luft R. On the intravenous glucose tolerance test. Acta Endocrinol (Kbh) 1957; 25: 312–333.
   Google Scholar
• Kim H, Kalkhoff RK, Costrini NV, Cerletty JM, Jacob-sen M. Plasma insulin disturbance in primary hyperparathyroidism. J Clin Invest 1971; 50: 2596–2605.
   Google Scholar
• Lind L, Wengle B, Ljunghall S. Blood pressure is lowered by vitamin D (alphacalcidol) during long-term treatment of patients with intermittent hypercal-caemia. A double-blind, placebo-controlled, study. Acta Med Scand 1987; 222: 423–427.
   Google Scholar
• Lind L, Wengle B, Wide L, Wrege U, Ljunghall S. Suppression of serum parathyroid hormone levels by intravenous alphacalcidol in uremic patients on maintenance hemodialysis—a pilot study. Nephrol in press.
   Google Scholar
• Lindall A, Carmena R, Cohen S, Comty C. Insulin hypersecretion in patients on chronic hemodialysis, role of the parathyroids. J Clin Endocrinol Metab 1971; 32: 653–658.
   Google Scholar
• Ljunghall S, Lithell H, Vessby B, Wide L. Glucose and lipoprotein metabolism in primary hyperparathyroidism. Effects of parathyroidectomy. Acta Endocrinol (Kbh) 1978; 89: 580–589.
   Google Scholar
• Ljunghall S, Palm6r M, Akerstrom G, Wide L. Diabetes mellitus, glucose tolerance and insulin response to glucose in patients with primary hyperparathyroidism before and after parathyroidectomy. Eur J Clin Invest 1983; 13: 373–377.
   Google Scholar
• Madsen S. Calcium and phosphate metabolism in chronic renal failure, with particular reference to the effect of 1-alphahydroxyvitamin D. Acta Med Scand 1979; Suppl 636.
   Google Scholar
• Mak RHK, Bettinelli A, Turner C, Haycock GB, Dhantler C. The influence of hyperparathyroidism on glucose metabolism in uremia. J Clin Endocrinol Metab 1985; 60: 229–233.
   Google Scholar
• Massry SG. Is parathyroid hormone a uremic toxin% Nephron 1977; 19: 125–130.
   Google Scholar
• McCarron DA, Morris CF. Blood pressure response to oral calcium in persons with mild to moderate hypertension: a randomized double-blind placebo-controlled crossover trial. Ann Intern Med 1985; 103: 825–831.
   Google Scholar
• McCarron DA, Pingree PA, Rubin RJ, Gaucher SM, Molitich M, Krutzik S. Enhanced parathyroid function in essential hypertension: a homeostatic response to a urinary calcium leak. Hypertension 1980; 2: 162–168.
   Google Scholar
• Nilsson P, Malmaeus J, Melsen F, Danielson BG, Mosekilde L. Relationship between calcium and phosphorus homeostasis, parathyroid hormone levels, bone aluminium and bone histomorphometry in patients on maintenance hemodialysis. Bone 1985; 6: 21–27.
   Google Scholar
• Norbeck HE. Serum lipoproteins in chronic renal failure. Acta Med Scand 1981; Suppl 649.
   Google Scholar
• Norman AW, Frankel BJ, Heldt AM, Grodsky GM. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 1980; 209: 823–825.
   Google Scholar
• Slatopolsky E, Weerts C, Thielan J, Horst R, Harter H, Martin KJ. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients. J Clin Invest 1984; 74: 2136–2143.
   Google Scholar
• Strazzullo P, Nunziata V, Cirillo M, Giannatasio R, Fer-rar LA, Mattioli PL, Manchini M. Abnormalities of calcium metabolism in essential hypertension. Clin ScH983; 65: 137–141.
   Google Scholar
• Weidmann P, Beretta-Piccoli C, Stcffen F, Blumberg A, Reubi F. Hypertension in terminal renal failure. Kidney Int 1976; 9: 294–301.
   Google Scholar